Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
27.10
+0.10 (0.37%)
At close: Jan 13, 2026, 4:00 PM EST
27.10
0.00 (0.00%)
After-hours: Jan 13, 2026, 6:40 PM EST
Rapport Therapeutics Employees
Rapport Therapeutics had 69 employees as of December 31, 2024.
Employees
69
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,415,942
Market Cap
1.29B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 69 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RAPP News
- 6 days ago - Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline - GlobeNewsWire
- 26 days ago - Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219's Clinical Response in Patients with Focal Onset Seizures - GlobeNewsWire
- 7 weeks ago - Rapport Therapeutics to Present New Phase 2a Data Analysis Further Characterizing RAP-219 in Focal Onset Seizures at 2025 American Epilepsy Society Annual Meeting - GlobeNewsWire
- 2 months ago - Rapport Therapeutics Reports Third Quarter 2025 Financials and Provides Business Update - GlobeNewsWire
- 2 months ago - Rapport Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Biotech is back. Here's why these rallying stocks belong in your portfolio now. - Market Watch
- 3 months ago - Rapport Acquires Aquifer Motion, Becoming the First Company to Offer Real-Time, AI-Powered Avatars with Full-Body Animation - Business Wire